Gene therapy shot could ease knee pain – early trial launches

NCT ID NCT07198555

Recruiting now Disease control Sponsor: Belief BioMed (Beijing) Co., Ltd Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 30 times

Summary

This early-stage study tests a new gene therapy called BBM-A101 for people with moderate knee osteoarthritis. The goal is to see if it is safe and can help reduce pain or improve joint function. About 81 adults with knee arthritis will receive the treatment and be monitored for side effects and any signs of benefit.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Shenzhen Second People's Hospital
RECRUITING

Shenzhen, Guangdong, 518035, China

Contact Phone: •••-•••-•••• Email: •••••@•••••
The Ninth People's Hospital of Shanghai Jiao Tong University School of Medicine
RECRUITING

Shanghai, Shanghai Municipality, 200011, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

KNEE OSTEOARTHRITIS